Institute of Molecular and Clinical Ophthalmology Basel (IOB) at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Institute of Molecular and Clinical Ophthalmology Basel (IOB) brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on precision therapies for blinding eye disease. It also covers an adherent production platform that turns out hundreds of different AAV preparations quickly for basic research.

OrganizationESGCT 2026 Attendance
iob.ch
Universities & institutes
Basel research institute studying vision and developing gene therapies and optogenetics for blinding eye diseases.
Talk
Wed Oct 28
11:30am–12:30pm
Precision therapies for visual diseases
SESSION 4a: CNS & sensory I
Rare and inherited disease
Poster
Thu Oct 29
2:00pm–4:00pm
High-variety AAV production(n=549) at speed: a scalable adherent platform for basic research
AAVs / non integrative vectors

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Institute of Molecular and Clinical Ophthalmology Basel (IOB)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction